Ned Scheetz

Director at ClearFlow

Mr. Scheetz founded Aphelion Capital, LLC in 2005. Prior to forming Aphelion, Mr. Scheetz was a partner and managing director with Piper Jaffray Ventures (PJV) for nearly eight years, focusing on investments in emerging medical technology companies. Mr. Scheetz joined PJV from Janus Capital, where he was a senior research analyst covering medical technology. Before beginning his investment career Mr. Scheetz worked in various product management roles with a subsidiary of Eastman Kodak and in sales with Kraft General Foods.

Mr. Scheetz is a graduate of Colby College, Duke University’s Fuqua School of Business, and was a post-graduate scholar at Oxford University. Mr. Scheetz holds the CFA designation, and is a board member of ClearFlow, Curant, OrthAlign, and SurgiQuest. Mr. Scheetz is an advisory board member with the Center for Medical Device Innovation, and on the business advisory board of The Epilepsy Therapy Development Project.

Location

Denver, United States

Links


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


ClearFlow

1 followers

Prevent the retention of blood and fluids in your patients with a unique system that proactively clears chest tubes. Developed by cardiothoracic surgeons, PleuraFlow ACT avoids post-surgical fluid collection, the root cause of Retained Blood Syndrome.


Industries

Employees

11-50

Links